Science | Relationships and health

Champions of ‘skinny jab’ paid by drug maker

False advertising? Manufacturers of the drug spent £21.7 million on an “orchestrated PR campaign".

Are we cancelling free will? A new drug promises to end obesity with a quick weekly jab. Some think it is a huge step forward. Others say it is a bad idea.

Continue Reading

To access this article and more news for schools, try The Day now.

Start your free trial Already have an account? Log in / register